Assessment of chest pain patients remains a clinical challenge in the emergency department (ED). Several randomized controlled trials (RCTs) have shown the additive value of coronary computed tomographic angiography (CCTA) compared with standard care. Not all of them, however, had enough power to detect differences in clinical outcomes like revascularization. Therefore, we performed a meta-analysis to test the safety and efficacy of this non-invasive diagnostic approach in low-and intermediate-risk chest pain patients.
Introduction
Chest pain represents one of the most common reasons for admission to an emergency department (ED), with up to eight million patients with clinical suspicion of acute coronary syndrome (ACS) 1, 2 presenting each year in the USA.
These patients present a clinical challenge: up to 85% of them will be shown not to have active cardiac ischaemia, but many of them are admitted to hospital, due to the risk of missing adverse events. Despite new and more sensitive clinical biomarkers, clinical decision rules, and risk scores, 3 -8 concerns regarding presentation with atypical symptoms along with the negative consequences of failing to detect ACS drive both ED physicians and cardiologists to take a more cautious approach. While the latter may reduce diagnostic errors, it is certainly time-consuming and more expensive, accounting for up to $10-12 billion annually in the USA. 8 Nonetheless, 2-5% of time-sensitive ACS cases are still missed, 9 -11 and underdiagnosed ACS accounts for 30% of all malpractice judgements. 12 The definitive way to exclude active ischaemia is demonstration of a disease-free coronary system, as negative coronary angiography engenders a low risk of future cardiac events. 13, 14 Coronary computed tomographic angiography (CCTA) is a non-invasive test with a negative predictive value (NPV) of approximately 100% for detection of coronary artery stenosis compared with catheter angiography. 15 It also allows an accurate assessment of the severity of coronary stenosis. 16 -19 Clinical application of CCTA has been assessed in several observational studies and has shown good efficacy in terms of detection of coronary disease as well as economic advantages.
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Several randomized controlled trials (RCTs) have shown the additive value of CCTA compared with standard care but were under-powered to detect differences in clinical outcomes, like rates of revascularization. Therefore, we performed a meta-analysis to evaluate the safety and efficacy of this non-invasive diagnostic approach in low-and intermediate-risk chest pain patients.
Methods

Data sources
The terms 'Coronary computed tomographic angiography or CCTA', 'Emergency Department', and 'chest pain or acute coronary syndrome' were searched across MEDLINE, EMBASE, and Cochrane databases according to optimal search strategies. 20 Reference lists of included articles were also reviewed. No language restrictions were imposed. The corresponding authors of all shortlisted studies were directly contacted for additional data and invited to participate in data analysis and interpretation, as well as suggestions of additional studies.
Study selection
RCTs comparing a CCTA approach and a non-CCTA approach for patients presenting to the ED with chest pain were included.
The outcomes of interest were (a) safety outcomes including rates of coronary angiography and of revascularization during index visit and (b) efficacy outcome including time to diagnosis, rates of direct discharge from the ED, and costs of ED care.
Three investigators (G.B.Z., E.C., and F.D.A.) independently appraised titles, abstracts, and the full texts to determine whether studies met inclusion criteria. Conflicts between reviewers were resolved through re-review and discussion, Figure 1 .
Data extraction and quality assessment
Three authors (G.B.Z.; E.C.; F.D.A.) independently abstracted data on study design, setting, CCTA protocol, and control group protocol. Age, gender, cardiovascular risk factors, and clinical presentations were also evaluated. In-hospital outcomes were: direct discharge from ED, time to diagnosis, rates of coronary angiography, of revascularization (both percutaneous and surgical), and costs of care. The follow-up outcomes were the rates of ED re-admissions.
The quality of included trials was assessed according to Cochrane, PRISMA, and QUORUM statements 21, 22 ; methods to obtain sample size, selection bias (allocation and random sequence generation), performance bias (blinding of participants and personnel), detection bias (blinding of outcome assessment), and attrition bias (incomplete outcome data) were assessed and graphically described. Figure 1 Review's profile.
The Jadad Scale 23 was used to appraise the methodological quality of the included studies.
Data synthesis and analysis
Random-effects models were used to compute dichotomous comparisons. Fixed effects models were also tested and their results reported only if different from random effect. RevMan 5 (The Cochrane Collaboration, The Nordic Cochrane Centre, Copenhagen, Denmark) was used. Hypothesis testing for statistical homogeneity was set at the twotailed 0.10 level and based on the Cochran Q-test, with I 2 values of 25, 50, and 75% representing mild, moderate, and extensive statistical heterogeneity, respectively. A funnel plot analysis was performed to identify small study bias.
Results
The abstracts of 194 studies were initially appraised. Many of them were excluded for not meeting the inclusion criteria. In total, 10 further studies 9,15,24 -31 were excluded because of nonrandomized design.
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Finally, we included four randomized control trials with a total of 2567 patients (Tables 1 -3); their median age was 50 years (49.751.25), about half of them (48%; 47-50) were male, 39% (38 -45) suffered from hypertension, 34% (31 -35) were hyperlipidemic, and 11% (9-13) diabetic. The median thrombolysis in myocardial infarction (TIMI) risk score was 1.01 (0.07-1.24).
The inclusion and the exclusion criteria were similar; briefly the selected studies randomized patients presenting with chest pain to the ED, without ischaemic ECG changes or raised cardiac biomarkers, and not reporting a history of coronary artery disease (CAD).
With regard to in-hospital outcomes, patients in the CCTA group were more likely to undergo percutaneous or surgical revascularization during their index visit, with an odds ratio (OR) of 1.88 (1.21-2.92). Time to diagnosis was significantly reduced (27.68 h;212.70 to 2.66), along with costs of care in the ED (2$680; 21.060 to 2270: all confidence interval (CI) 95%), while rates of direct discharge were lower, although not significant (OR 1.53; 0.51-4.63).
Follow-up duration was of 6 months in 2 studies, and 2 months in the two remaining: no differences were reported in ED re-attendance (OR 0.94; 0.67 -1.32) (see Figures 2 -7) .
The risk of bias of included RCTs (evaluated both with JADAD scale and Cochrane) was low, especially regarding blinding and selection bias (Supplementary data online, Figure SA and Table SA) .
Discussion
This systematic review and meta-analysis showed that CCTA is a safe and efficacious strategy for low and intermediate risk patients presenting with chest pain to the ED.
CCTA offers the chance to exclude CAD safely in many ED patients, having also the potential to lead to additional diagnostic testing and therapeutic interventions. Although previous studies report good sensitivity and NPV, 36 potentially representing the aetiology of the ED presentation or merely an incidental finding. A feasible solution to this diagnostic challenge is the use of fractional flow reserve (FFR), which has a role in reducing unnecessary percutaneous coronary intervention and possibly rates of adverse cardiac events. 43 Recently, noninvasive FFR 44 derived from CCTA images has demonstrated encouraging results, but this technique has still to be investigated and validated in larger settings. CCTA may therefore represent the first step to detect atherosclerosis, allowing physicians to suggest appropriate lifestyle modification and pharmacological therapies, while percutaneous transluminal coronary angioplasty guided by FFR may avoid unnecessary stenting.
Both diagnostic strategies enable ED physicians to discharge a similar rate of patients, while the major advantage of CCTA is its ability to rule out any CAD rapidly, thereby facilitating the diagnosis and improving cost-effectiveness.
CCTA reduces costs of care in the ED, which are one of the growing concerns in modern health care. Over the last two decades, studies concerning acute chest pain management have demonstrated the usefulness of imaging techniques, with significant reductions in hospital admission rates, 43 Patients 30 years of age or older with signs or symptoms that were consistent with a possible ACS were eligible if the treating physician determined that they would require admission or objective testing to rule out an ACS the electrocardiogram (ECG at presentation did not reveal acute ischaemia, and if the patient had an initial thrombolysis in myocardial infarction risk score of 0-2).
Symptoms that were clearly non-cardiac in origin had a coexisting condition that necessitated admission regardless of whether they might have an ACS had had normal findings on Some argue that current studies lack a substantial true cost analysis, (e.g. for increased revascularization) and also fail to consider the large number of patients ineligible for the designed approach and the frequent requirement for additional downstream testing 48 ; however, these analyses have not considered the indirect effects of more rapid discharge on ED overcrowding. Moreover in a recent editorial, 49 it was reported that ROMICAT 2 suffered from bias because including patients only during 'weekday daytime hours'; however, a significant reduction in time to diagnosis persisted also after the exclusion of this limitation (OR 27.13; 210.90 to 23-30; all CI 95%). The CCTA approach shares several important limitations. At least 64-slice devices are now mandatory for optimal diagnostic accuracy, but this expensive equipment is not available in all EDs and even if available, its use may be limited by time pressures or by lack of appropriately skilled staff. 50 The use of ionizing radiation is another important concern. The often-reported estimated exposure is between 6 and 11 mSv, extending to 16 mSv if functional evaluation is performed; however, recent studies reported newer CT techniques providing lower amount of radiations, also when compared with other technology like single-photon emission computed tomography (SPECT). CCTA may be associated with a considerable x-ray exposure in women, who represent the majority of patients with less than high-risk chest pain seen in the ED (52% in this meta-analysis; also reported as prevalent in young women in a previous study 51 ). Unfortunately, a lack of data makes difficult to include a direct comparison between radiation's burden in the different strategies the future goal will be the introduction of novel techniques to minimize the CT dose while preserving an optimal diagnostic accuracy. 52, 53 Beyond the performance of CCTA, other factors may limit its use in ED patients. There may be un-interpretable segments on 64-slice CCTA, excessive cardiac motion, or prominent coronary artery calcification 54 -56 that may cause motion artefact preventing accurate interpretation of that segment. The most common reasons for not performing CCTA include renal insufficiency, arrhythmias or beta-blockers intolerance, suspected allergy, and an inability to complete the study because of contrast extravasation or claustrophobia. Overall, these conditions may limit performing CCTA to between 25 and 60% of ED chest pain patients. 57 -59 In our work, we could not perform an overall analysis on the percentage of patients undergoing CCTA. Only in the study of Litt et al. it was reported that CCTA examination could not be performed in 16% of subjects who were assigned to that group, most commonly as a consequence of elevated heart rate. Our meta-analysis has some limitations, typical of all reviews'. A low-risk of bias was reported for most of the included studies, inconsistency was ,50% for most of the examined outcomes, and no differences were found between random and fixed effects. The most important limitation in this study is the absence of longterm follow-up, which may increase knowledge about safety of CCTA. The other is the absence in one study of economical analysis, and in two, of the overall cost for the two arms, being limited to ED management. Moreover, the control group was based also on an imaging test, like scintigraphy, an approach that may not reflect every-day clinical practice. Another limitation is that the paper of Litt et al. reported all-cause re-admissions, while the others reported only 'chest pain': after excluding this paper, however, the significance did not change (OR 0.76 [0.44-1.31]; I 2 ¼ 0%). Moreover, under-powered sample size may explain the lack of significance both for rates of angiography and for direct discharge, the latter being influenced also from different definitions. In two studies, indeed, direct discharge was defined as discharge within 6 h. 34, 35 The present meta-analysis shows that a strategy with CCTA used as first imaging test for low-and intermediate-risk patients presenting to the ED with chest pain appears safe and seems not to increase subsequent invasive coronary angiographies. The approach appears cost-effective although limited data and incomplete cost analyses have been performed. CCTA increases coronary revascularizations, with a still unknown long term effect on prognosis.
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